James N. Campbell

James Campbell, M.D. is a founder, president and chief scientific officer of Centrexion Therapeutics. Jim is Professor Emeritus of neurosurgery at Johns Hopkins University School of Medicine. He has published over 100 peer-reviewed scientific studies in the field of pain research, which have been recognized through many national honors. In 1996, Jim was president of the American Pain Society. Prior to joining Centrexion, he served as the CEO of Arcion Therapeutics, a biotech company developing topical products for the treatment of neuropathic pain. Earlier in his career, he served as the CEO for Vallinex, Inc. He served as the founder of the American Pain Foundation and was chairman of the board for ten years. He also served as board observer and co-founder of CNS Therapeutics, and was co-founder and on the board of directors of Amplimmune. Jim holds a B.A. in psychology with high honors and high distinction from the University of Michigan, and received his M.D. from Yale University. He received his training in Neurosurgery at the Johns Hopkins Hospital, and is a Diplomate of the American Board of Neurological Surgery.